Dold M

Department of Psychiatry and Psychotherapy, Medical University of Vienna , ,

4 papers

ArticleKetamine

Improvements in Functioning with Esketamine Nasal Spray versus Quetiapine Extended Release in Patients with Treatment Resistant Depression

Vieta E, Ahmed N, Arango C +11

Europe PMC2025
ArticleKetamine

Esketamine in persistent long COVID with predominant psychiatric manifestations: A case series

Bozic I, Ivkic D, Reinfried L +11

Europe PMC2025
ArticleKetamine

The role of esketamine in persistent long COVID with predominant psychiatric manifestations.

Bozic I, Ivkic D, Reinfried L +11

Europe PMC2025
ArticleKetamine

Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study.

Vieta E, Ahmed N, Arango C +11

Europe PMC2025